Express Gene-to-AAV Production Service in Southeast Asia

Tired of long turnaround times and unreliable AAV production?

Our Express Gene-to-AAV service offers a streamlined and efficient solution to accelerate your research. By combining expert design, rapid production, and rigorous quality control, we deliver high-quality AAV vectors in just 4 weeks.

Our Express Gene-to-AAV Service Includes:

1. Gene Synthesis and Cloning:
   • Expert Design: Our experienced team designs optimal gene constructs.
   • Efficient Cloning: We utilize advanced cloning techniques to ensure rapid and accurate gene insertion.
2. AAV Vector Production:
   • High-Titer AAVs: We produce high-titer AAVs with a range of serotypes to maximize transduction efficiency.
   • Rigorous Quality Control: Our stringent quality control measures ensure purity, potency, and safety.
3. Comprehensive Quality Control:
   • Purity and Potency: We perform comprehensive tests to assess the purity and titer of your AAV vectors.
   • Safety Testing: We conduct rigorous safety testing to ensure compliance with regulatory standards.

What do you get from our Express Gene-to-AAV Service?

1. AAV Vector: High-quality AAV vector, ready for your research experiments.
2. Detailed Quality Control Report: Comprehensive documentation of vector quality and performance.
3. Plasmid Map and Sequence: Detailed information about the plasmid construct used for AAV production.
4. Customizable Reporting: Tailored reports to meet your specific needs.

Why Choose PackGene?

• Rapid Turnaround Time: Experience accelerated timelines with our efficient production process.
• Customizable Solutions: Tailor your AAV vectors to your specific research needs, including serotype, promoter, and transgene selection.
• Unmatched Quality: Benefit from our commitment to quality, ensuring consistent and reliable results.
• Expert Technical Support: Experienced team provides guidance and support throughout the entire process.
• Competitive Pricing: Cost-effective solutions help you maximize your budget.

Case Study

• Case 1

• Case 2

• Case 3

• Case 4

• Spinal muscular atrophy with myoclonic epilepsy (SMA-PME, ASAH1 gene defect)
• Single dose, intrathecal and intracerebroventricular injection.

• OTOF biallelic mutations cause severe hearing impairment or complete hearing loss.
• Single dose, cochlear injection.

• Advanced blindness caused by retinitis pigmentosa.
• Single dose, intraocular intravitreal injection.

• Amyotrophic lateral sclerosis (ALS).
• Single dose, intrathecal injection.

Your Success, Our Priority

By choosing PackGene, you’re investing in a partnership dedicated to your research success. Our team is committed to providing exceptional service and delivering high-quality AAV vectors.

Contact us today to discuss your specific research needs and learn how our Express Gene-to-AAV service can accelerate your scientific discoveries.